Clinical Trial Update: A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating neoadjuvant chemoimmunotherapy with immunosensitizing radiation for border-line resectable non-s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemoimmunotherapy with immunosensitizing radiation (neoadjuvant)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: RECRUITING